tetano
Editor, Senior Moderator
Microbiol Resour Announc
. 2024 Nov 12:e0078924.
doi: 10.1128/mra.00789-24. Online ahead of print. Genomic surveillance of SARS-CoV-2 in Nepal
Binod Khadka[SUP] 1 [/SUP], Rajindra Napit[SUP] 1 2 [/SUP], Kathie A Mihindukulasuriya[SUP] 3 4 5 [/SUP], Smita Shrestha[SUP] 1 [/SUP], Ramanuj Rauniyar[SUP] 1 [/SUP], Eans T Tuladhar[SUP] 1 6 [/SUP], Lindsay Droit[SUP] 3 4 [/SUP], Anne M Paredes[SUP] 4 [/SUP], Runa Jha[SUP] 7 [/SUP], Roji Raut[SUP] 1 2 [/SUP], Bimalesh K Jha[SUP] 7 [/SUP], Scott A Handley[SUP] 4 5 [/SUP], Annie Elong-Ngono[SUP] 8 [/SUP], Sujan Shresta[SUP] 8 [/SUP], David Wang[SUP] 3 [/SUP], Krishna D Manandhar[SUP] 1 [/SUP]
Affiliations
During the COVID-19 pandemic, Nepal, like other countries, faced emerging SARS-CoV-2 variants. To evaluate the circulating variants, 278 samples collected between September 2021 and March 2022 were sequenced in the country. From these, 229 high-quality genomes were obtained (82.97% Omicron and 17.03% Delta) highlighting the genomic diversity of SARS-CoV-2 in Nepal.
Keywords: COVID-19; Illumina; coronavirus; whole-genome sequencing.
. 2024 Nov 12:e0078924.
doi: 10.1128/mra.00789-24. Online ahead of print. Genomic surveillance of SARS-CoV-2 in Nepal
Binod Khadka[SUP] 1 [/SUP], Rajindra Napit[SUP] 1 2 [/SUP], Kathie A Mihindukulasuriya[SUP] 3 4 5 [/SUP], Smita Shrestha[SUP] 1 [/SUP], Ramanuj Rauniyar[SUP] 1 [/SUP], Eans T Tuladhar[SUP] 1 6 [/SUP], Lindsay Droit[SUP] 3 4 [/SUP], Anne M Paredes[SUP] 4 [/SUP], Runa Jha[SUP] 7 [/SUP], Roji Raut[SUP] 1 2 [/SUP], Bimalesh K Jha[SUP] 7 [/SUP], Scott A Handley[SUP] 4 5 [/SUP], Annie Elong-Ngono[SUP] 8 [/SUP], Sujan Shresta[SUP] 8 [/SUP], David Wang[SUP] 3 [/SUP], Krishna D Manandhar[SUP] 1 [/SUP]
Affiliations
- PMID: 39530702
- DOI: 10.1128/mra.00789-24
During the COVID-19 pandemic, Nepal, like other countries, faced emerging SARS-CoV-2 variants. To evaluate the circulating variants, 278 samples collected between September 2021 and March 2022 were sequenced in the country. From these, 229 high-quality genomes were obtained (82.97% Omicron and 17.03% Delta) highlighting the genomic diversity of SARS-CoV-2 in Nepal.
Keywords: COVID-19; Illumina; coronavirus; whole-genome sequencing.